New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1

James C. Anthony, David Vlahov, Kenrad Edwin Nelson, Sylvia Conn, Jacqueline Astemborski, Liza Solomon

Research output: Contribution to journalArticle

Abstract

To examine whether recent intravenous use of cocaine might be associated with increased risk of human immunodeficiency virus type 1 (HIV) infection, the authors studied 2,597 active intravenous drug users: 2,399 with recent cocaine injection and 198 with recent injection of heroin or other drugs but not cocaine. These subjects were adult residents of Baltimore City and the surrounding Maryland counties, recruited via outreach into the community between February 1988 and March 1989. In contrast to the first report on the cocaine-HIV association, the present study sample was not recruited solely from drug treatment programs. In the present study, estimated HIV seroprevalence was 26.4% for recent cocaine injectors as compared with 10.6% among all other recent intravenous drug users; the relative odds estimate was 3.03. In the untreated segment of the sample, HIV seroprevalence was 26.0% for recent cocaine injectors as compared with 8.9% among others (relative odds (RO) = 3.61). The estimated degree of association did not change appreciably when multiple logistic regression was used to hold constant potentially confounding and/or mediating variables such as receptive anal intercourse, number of sex partners, and use of injection equipment obtained at shooting galleries (RO = 2.64). Augmenting these cross-sectional data, preliminary prospective data showed excess risk of HIV seroconversion among recent cocaine injectors (estimated relative risk = 2.11). While other research has examined the cocaine-HIV association, the present study differs in that it has allowed a test for whether the association was a spurious artifact of studying drug users recruited solely from drug treatment programs, a broad array of alternative determinants of HIV infection have been held constant, and the association has been examined with seroconversion data. The results lend support to the abiding concern about the risk of HIV infection among cocaine users. Am J Epidemiol 1991 ;134:1175-89.

Original languageEnglish (US)
Pages (from-to)1175-1189
Number of pages15
JournalAmerican Journal of Epidemiology
Volume134
Issue number10
StatePublished - Nov 15 1991

Fingerprint

Cocaine
HIV-1
Infection
Virus Diseases
Drug Users
Odds Ratio
Seroepidemiologic Studies
Injections
Pharmaceutical Preparations
Baltimore
Heroin
Artifacts
Logistic Models
Equipment and Supplies
Therapeutics
Research

Keywords

  • AIDS-related complex
  • Cocaine
  • Injections
  • Intravenous
  • Substance use disorders

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Epidemiology

Cite this

New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. / Anthony, James C.; Vlahov, David; Nelson, Kenrad Edwin; Conn, Sylvia; Astemborski, Jacqueline; Solomon, Liza.

In: American Journal of Epidemiology, Vol. 134, No. 10, 15.11.1991, p. 1175-1189.

Research output: Contribution to journalArticle

Anthony, JC, Vlahov, D, Nelson, KE, Conn, S, Astemborski, J & Solomon, L 1991, 'New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1', American Journal of Epidemiology, vol. 134, no. 10, pp. 1175-1189.
Anthony, James C. ; Vlahov, David ; Nelson, Kenrad Edwin ; Conn, Sylvia ; Astemborski, Jacqueline ; Solomon, Liza. / New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. In: American Journal of Epidemiology. 1991 ; Vol. 134, No. 10. pp. 1175-1189.
@article{a8e6d654157844859e3f3734597c33df,
title = "New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1",
abstract = "To examine whether recent intravenous use of cocaine might be associated with increased risk of human immunodeficiency virus type 1 (HIV) infection, the authors studied 2,597 active intravenous drug users: 2,399 with recent cocaine injection and 198 with recent injection of heroin or other drugs but not cocaine. These subjects were adult residents of Baltimore City and the surrounding Maryland counties, recruited via outreach into the community between February 1988 and March 1989. In contrast to the first report on the cocaine-HIV association, the present study sample was not recruited solely from drug treatment programs. In the present study, estimated HIV seroprevalence was 26.4{\%} for recent cocaine injectors as compared with 10.6{\%} among all other recent intravenous drug users; the relative odds estimate was 3.03. In the untreated segment of the sample, HIV seroprevalence was 26.0{\%} for recent cocaine injectors as compared with 8.9{\%} among others (relative odds (RO) = 3.61). The estimated degree of association did not change appreciably when multiple logistic regression was used to hold constant potentially confounding and/or mediating variables such as receptive anal intercourse, number of sex partners, and use of injection equipment obtained at shooting galleries (RO = 2.64). Augmenting these cross-sectional data, preliminary prospective data showed excess risk of HIV seroconversion among recent cocaine injectors (estimated relative risk = 2.11). While other research has examined the cocaine-HIV association, the present study differs in that it has allowed a test for whether the association was a spurious artifact of studying drug users recruited solely from drug treatment programs, a broad array of alternative determinants of HIV infection have been held constant, and the association has been examined with seroconversion data. The results lend support to the abiding concern about the risk of HIV infection among cocaine users. Am J Epidemiol 1991 ;134:1175-89.",
keywords = "AIDS-related complex, Cocaine, Injections, Intravenous, Substance use disorders",
author = "Anthony, {James C.} and David Vlahov and Nelson, {Kenrad Edwin} and Sylvia Conn and Jacqueline Astemborski and Liza Solomon",
year = "1991",
month = "11",
day = "15",
language = "English (US)",
volume = "134",
pages = "1175--1189",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1

AU - Anthony, James C.

AU - Vlahov, David

AU - Nelson, Kenrad Edwin

AU - Conn, Sylvia

AU - Astemborski, Jacqueline

AU - Solomon, Liza

PY - 1991/11/15

Y1 - 1991/11/15

N2 - To examine whether recent intravenous use of cocaine might be associated with increased risk of human immunodeficiency virus type 1 (HIV) infection, the authors studied 2,597 active intravenous drug users: 2,399 with recent cocaine injection and 198 with recent injection of heroin or other drugs but not cocaine. These subjects were adult residents of Baltimore City and the surrounding Maryland counties, recruited via outreach into the community between February 1988 and March 1989. In contrast to the first report on the cocaine-HIV association, the present study sample was not recruited solely from drug treatment programs. In the present study, estimated HIV seroprevalence was 26.4% for recent cocaine injectors as compared with 10.6% among all other recent intravenous drug users; the relative odds estimate was 3.03. In the untreated segment of the sample, HIV seroprevalence was 26.0% for recent cocaine injectors as compared with 8.9% among others (relative odds (RO) = 3.61). The estimated degree of association did not change appreciably when multiple logistic regression was used to hold constant potentially confounding and/or mediating variables such as receptive anal intercourse, number of sex partners, and use of injection equipment obtained at shooting galleries (RO = 2.64). Augmenting these cross-sectional data, preliminary prospective data showed excess risk of HIV seroconversion among recent cocaine injectors (estimated relative risk = 2.11). While other research has examined the cocaine-HIV association, the present study differs in that it has allowed a test for whether the association was a spurious artifact of studying drug users recruited solely from drug treatment programs, a broad array of alternative determinants of HIV infection have been held constant, and the association has been examined with seroconversion data. The results lend support to the abiding concern about the risk of HIV infection among cocaine users. Am J Epidemiol 1991 ;134:1175-89.

AB - To examine whether recent intravenous use of cocaine might be associated with increased risk of human immunodeficiency virus type 1 (HIV) infection, the authors studied 2,597 active intravenous drug users: 2,399 with recent cocaine injection and 198 with recent injection of heroin or other drugs but not cocaine. These subjects were adult residents of Baltimore City and the surrounding Maryland counties, recruited via outreach into the community between February 1988 and March 1989. In contrast to the first report on the cocaine-HIV association, the present study sample was not recruited solely from drug treatment programs. In the present study, estimated HIV seroprevalence was 26.4% for recent cocaine injectors as compared with 10.6% among all other recent intravenous drug users; the relative odds estimate was 3.03. In the untreated segment of the sample, HIV seroprevalence was 26.0% for recent cocaine injectors as compared with 8.9% among others (relative odds (RO) = 3.61). The estimated degree of association did not change appreciably when multiple logistic regression was used to hold constant potentially confounding and/or mediating variables such as receptive anal intercourse, number of sex partners, and use of injection equipment obtained at shooting galleries (RO = 2.64). Augmenting these cross-sectional data, preliminary prospective data showed excess risk of HIV seroconversion among recent cocaine injectors (estimated relative risk = 2.11). While other research has examined the cocaine-HIV association, the present study differs in that it has allowed a test for whether the association was a spurious artifact of studying drug users recruited solely from drug treatment programs, a broad array of alternative determinants of HIV infection have been held constant, and the association has been examined with seroconversion data. The results lend support to the abiding concern about the risk of HIV infection among cocaine users. Am J Epidemiol 1991 ;134:1175-89.

KW - AIDS-related complex

KW - Cocaine

KW - Injections

KW - Intravenous

KW - Substance use disorders

UR - http://www.scopus.com/inward/record.url?scp=0026322021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026322021&partnerID=8YFLogxK

M3 - Article

C2 - 1746528

AN - SCOPUS:0026322021

VL - 134

SP - 1175

EP - 1189

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 10

ER -